You are here

  • Home
  • Archive
  • Volume 74, Issue 2
  • Development, internal validation and calibration of a risk score to predict survival in patients with EGFR-mutant non-small cell lung cancer

Article metrics

Article menu
Download PDFPDF
Original research
Development, internal validation and calibration of a risk score to predict survival in patients with EGFR-mutant non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: June 2020 to August 2023

AbstractFullPdf
Jun 20203432714
Jul 202033995
Aug 20204122
Sep 20209121
Oct 20206635
Nov 20206134
Dec 20205551
Jan 20214582713
Feb 20212972118
Mar 202116163
Apr 2021124108
May 20215162
Jun 2021763
Jul 20211064
Aug 2021631
Sep 202116138
Oct 20217743
Nov 202111130
Dec 20219050
Jan 2022112100
Feb 202210942
Mar 202212912
Apr 20228931
May 202215723
Jun 20228252
Jul 202210954
Aug 2022104112
Sep 202217972
Oct 202218810
Nov 20226850
Dec 20226752
Jan 20232600
Feb 20239830
Mar 20233342
Apr 20239742
May 20236532
Jun 20232101
Jul 20235340
Aug 20233000
Total4220238122